Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

GreenLight Biosciences Holdings (GRNA)

0.2995   -0 (-0.03%) 07-21 16:00
Open: 0.2995 Pre. Close: 0.2996
High: 0.304 Low: 0.2993
Volume: 143,167 Market Cap: 45(M)

Technical analysis

as of: 2023-09-01 4:47:29 PM
Short-term rate:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Mid-term rate:       
Target: Six months: 0.35     One year: 0.41
Support: Support1: 0.29    Support2: 0.29
Resistance: Resistance1: 0.3    Resistance2: 0.35
Pivot: 0.29
Moving Average: MA(5): 0.29     MA(20): 0.29
MA(100): 0.32     MA(250): 1.2
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 43.7     %D(3): 43.7
RSI: RSI(14): 59
52-week: High: 5.9  Low: 0.17
Average Vol(K): 3-Month: 683 (K)  10-Days: 121 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ GRNA ] has closed below upper band by 23.4%. Bollinger Bands are 97.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 28 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.3 - 0.3 0.3 - 0.3
Low: 0.3 - 0.3 0.3 - 0.3
Close: 0.3 - 0.3 0.3 - 0.3

Company Description

GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.

Headline News

Mon, 24 Jul 2023
GreenLight Announces Completion of Merger with Fall Line Endurance Fund - Yahoo Finance

Thu, 20 Jul 2023
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares - Yahoo Finance

Thu, 15 Jun 2023
SHAREHOLDER ALERT: Kaskela Law LLC Announces ... - PR Newswire

Tue, 13 Jun 2023
RNA company to lay off 96 employees in Lexington - Boston ... - The Business Journals

Mon, 05 Jun 2023
GRNA ALERT: Levi & Korsinsky, LLP Announces an Investigation of ... - PR Newswire

Tue, 30 May 2023
GreenLight Biosciences Enters into Definitive Merger Agreement ... - GlobeNewswire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 0 (M)
% Held by Insiders 0 (%)
% Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.